Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Semiconductor device and method of forming interconnect structure with conductive pads having expanded interconnect surface area for enhanced interconnection properties
Nanocatalysts structure, process for the preparation and use thereof
Inkjet ink
Particle measurement process and apparatus
Flame-proofed thermoplastic compositions
Method for fabricating a nitrided silicon-oxide gate dielectric
Stroboscopic light source for a transmitter of a large scale metrology system
  Randomly Featured Patents
Space saver
Cutting apparatus for medical tubes
Cat climbing pole
Digital controller for a voltage regulator module
Biometrics authentication system
Process for polymerizing high melt index olefins and polymerization catalysts used therefore
Method and device for determining the blood flow in a blood-conducting tube
Transitioning network traffic between logical partitions in one or more data processing systems
Applying segment conditions to measure results